查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1917790

初代细胞培养市场－2026-2031年预测

Primary Cell Culture Market - Forecast from 2026 to 2031
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 145 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

预计初代细胞培养市场将从 2025 年的 19.64 亿美元成长到 2031 年的 30.89 亿美元，复合年增长率为 7.84%。

由于对直接从组织中分离的细胞的需求迅速增长，初代细胞培养市场正在扩张，这推动了个人化和再生医学的发展。研究人员正在利用生理相关的癌症模型中的初代细胞来加速药物筛检和治疗方法检验。生物技术公司越来越多地采用酵素消化法，该方法能够温和、有效率地提取细胞。生物医学研究实验室正在拓展初代细胞三维培养的应用，以实现更逼真的体内模拟。

初代细胞培养是一种透过机械或酶解法从生物组织或器官中分离并培养细胞的技术，与永生化细胞株相比，它能保留细胞的固有特性，并具有更高的生物学相关性。这些培养系统能够提供反映供体组织的异质性细胞群，从而可以精确模拟生理过程、药理反应和毒理效应。在药物研发、再生医学和疾病建模等领域，对体内环境的逼真模拟至关重要，因此原代细胞培养市场正在稳步成长。

慢性疾病成长要素日益加重，包括癌症、糖尿病、心血管疾病、自体免疫疾病和肾臟疾病，是推动细胞治疗发展的关键因素，因此亟需强大的临床前治疗评估平台。原代细胞在细胞和基因治疗开发中的广泛应用，凸显了其在利用自体或异体细胞来源进行修復应用方面的重要作用。酵素消化，尤其是基于胰蛋白酶的通讯协定，因其细胞损伤小、处理速度快、产量高等优点，越来越受到青睐，优于机械处理方法。三维培养系统的进步充分利用了初代细胞固有的真实性，模拟了二维单层培养无法实现的多细胞结构和细胞外基质相互作用。动物源性初代细胞的日益普及，为疫苗生产和毒理学研究提供了支持，目前已有来自小鼠、大鼠和猪等物种的成熟模型可供使用。

从区域来看，由于医疗保健成本不断上涨、人口老化、慢性病高发生率以及政府对生物医学研究的大量投入，北美预计将占据主要市场份额。亚太地区预计将实现强劲成长，这主要得益于干细胞治疗的成本优势、再生医学领域积极的研发活动以及细胞和基因疗法生产能力的不断提高。

主要企业包括 Thermo Fisher Scientific, Inc.、Lonza、Merck KGaA、Corning Incorporated 和 Danaher，它们提供全面的产品组合，包括分离试剂盒、培养基、基材和特殊试剂，这些产品针对各种细胞类型（包括上皮细胞、纤维母细胞细胞、成纤维细胞和干细胞）的原代细胞活力、增殖和表型产品系列。

整体而言，随着全球对慢性病管理和个人化医疗的需求不断增长，市场正稳步发展，并透过提高分离效率、3D 可重复性和转化相关性，成为精准医疗、肿瘤建模和再生策略的基础推动因素。

本报告的主要优势：

  • 深入分析：提供对主要和新兴地区的深入市场洞察，重点关注客户群、政府政策和社会经济因素、消费者偏好、行业垂直领域和其他细分市场。
  • 竞争格局：了解全球主要参与者的策略倡议，并了解透过正确的策略实现市场渗透的潜力。
  • 市场驱动因素与未来趋势：探索市场驱动因素和关键趋势及其对未来市场发展的影响。
  • 可操作的建议：利用这些见解，在快速变化的环境中做出策略决策，并发现新的商机和收入来源。
  • 受众广泛：适用于Start-Ups、研究机构、顾问公司、中小企业和大型企业，且经济实惠。

企业如何使用我们的报告？

产业与市场分析、机会评估、产品需求预测、打入市场策略、地理扩张、资本投资决策、法规结构及影响、新产品开发、竞争情报

研究范围：

  • 2021年至2025年的历史数据和2026年至2031年的预测数据
  • 成长机会、挑战、供应链前景、法规结构与趋势分析
  • 竞争定位、策略和市场占有率分析
  • 按业务板块和地区分類的收入和预测评估，包括国家/地区
  • 公司概况（策略、产品、财务资讯、关键发展等）

目录

第一章执行摘要

第二章 市场概览

  • 市场概览
  • 市场定义
  • 调查范围
  • 市场区隔

第三章 商业情境

  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 波特五力分析
  • 产业价值链分析
  • 政策与法规
  • 策略建议

第四章 技术展望

第五章 依细胞类型初代细胞培养市场

  • 介绍
  • 上皮细胞
  • 纤维母细胞
  • 角质形成细胞
  • 肌肉细胞
  • 其他的

第六章 按类型分類的初代细胞培养市场

  • 介绍
  • 人类
  • 动物

第七章初代细胞培养市场：依方法划分

  • 介绍
  • 机械分散法
  • 酵素分散法
  • 原位移植法

第八章初代细胞培养市场：依应用划分

  • 介绍
  • 癌症研究
  • 基因工程
  • 疫苗生产
  • 病毒学
  • 药物筛检和毒性测试
  • 其他的

第九章初代细胞培养市场：依最终用户划分

  • 介绍
  • 製药和生物技术公司
  • 研究和学术机构
  • 其他的

第十章初代细胞培养市场：依地区划分

  • 介绍
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 西班牙
    • 其他的
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 其他的
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 印尼
    • 泰国
    • 其他的

第十一章 竞争格局与分析

  • 主要企业和策略分析
  • 市占率分析
  • 合併、收购、协议和合作
  • 竞争对手仪錶板

第十二章：公司简介

  • Thermo Fisher Scientific, Inc.
  • Lonza
  • Merck KgaA
  • Corning Incorporated
  • Danaher Corporation
  • PromoCell GmbH
  • ATCC
  • FUJIFILM Corporation
  • Mattek（Sartorius）
  • Axol Bioscience Ltd
  • STEMCELL Technologies Inc.

第十三章附录

  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关人员的主要收益
  • 调查方法
  • 简称
简介目录
Product Code: KSI061615763

Primary Cell Culture Market, growing at a 7.84% CAGR, is projected to achieve USD 3.089 billion in 2031 from USD 1.964 billion in 2025.

The primary cell culture market is expanding as demand surges for cells directly isolated from tissues, supporting advancements in personalized and regenerative therapies. Researchers are leveraging primary cells for physiologically relevant cancer models to accelerate drug screening and treatment validation. Biotech firms are favoring enzymatic degradation methods for gentle, high-yield cell extraction. Biomedical laboratories are broadening 3D culture applications with primary cells to achieve realistic in vivo simulations.

Primary cell culture involves isolating and cultivating cells from living tissues or organs via mechanical or enzymatic dissociation, preserving native characteristics for superior biological relevance compared to immortalized lines. These cultures offer heterogeneous populations mirroring donor tissue, enabling accurate modeling of physiological processes, pharmacological responses, and toxicological effects. The market is growing steadily, driven by needs in drug discovery, regenerative medicine, and disease modeling where fidelity to in vivo conditions is paramount.

Key growth drivers include the escalating burden of chronic diseases-such as cancer, diabetes, cardiovascular disorders, autoimmune conditions, and nephrological issues-necessitating robust preclinical platforms for therapeutic evaluation. Rising utilization in cell and gene therapy development underscores primary cells' role in manipulating autologous or allogeneic sources for restorative applications. Increasing preference for enzymatic degradation, particularly trypsin-based protocols, stems from minimized cellular damage, rapid processing, and superior yields over mechanical alternatives. Advancements in 3D culture systems capitalize on primary cells' innate realism to recapitulate multicellular architectures and extracellular matrix interactions absent in 2D monolayers. Expanding use of animal-derived primary cells supports vaccine production and toxicology studies due to well-characterized models from species like mice, rats, and pigs.

Geographically, North America is predicted to hold significant share, attributed to elevated healthcare expenditures, aging demographics, high chronic disease prevalence, and substantial government funding for biomedical research. The Asia-Pacific region is anticipated for strong growth, fueled by cost advantages in stem cell procedures, burgeoning R&D in regenerative medicine, and increasing cell/gene therapy manufacturing.

Leading companies include Thermo Fisher Scientific, Inc., Lonza, Merck KGaA, Corning Incorporated, and Danaher. These entities provide comprehensive portfolios encompassing isolation kits, culture media, substrates, and specialized reagents optimized for primary cell viability, proliferation, and phenotypic stability across epithelial, endothelial, fibroblast, and stem cell types.

Overall, the market is progressing consistently, positioned to underpin precision therapeutics, oncology modeling, and regenerative strategies through enhanced isolation efficiency, 3D fidelity, and translational relevance, as chronic disease management and personalized medicine imperatives intensify globally.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2021 to 2025 & forecast data from 2026 to 2031
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.)

Primary Cell Culture Market Segmentation

  • By Cell Type
  • Epithelial Cell
  • Fibroblasts
  • Keratinocytes
  • Muscle Cells
  • Others
  • By Type
  • Human
  • Animal
  • By Method
  • Mechanical Disaggregation
  • Enzymatic Disaggregation
  • Primary Explant Technique
  • By Application
  • Cancer Research
  • Genetic Engineering
  • Vaccine Production
  • Virology
  • Drug Screening & Toxicity Testing
  • Others
  • By End-User
  • Pharmaceuticals & Bio-Tech Companies
  • Research & Academic Institute
  • Others
  • By Geography
  • North America
  • United States
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Others
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Thailand
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. PRIMARY CELL CULTURE MARKET BY CELL TYPE

  • 5.1. Introduction
  • 5.2. Epithelial Cell
  • 5.3. Fibroblasts
  • 5.4. Keratinocytes
  • 5.5. Muscle Cells
  • 5.6. Others

6. PRIMARY CELL CULTURE MARKET BY TYPE

  • 6.1. Introduction
  • 6.2. Human
  • 6.3. Animal

7. PRIMARY CELL CULTURE MARKET BY METHOD

  • 7.1. Introduction
  • 7.2. Mechanical Disaggregation
  • 7.3. Enzymatic Disaggregation
  • 7.4. Primary Explant Technique

8. PRIMARY CELL CULTURE MARKET BY APPLICATION

  • 8.1. Introduction
  • 8.2. Cancer Research
  • 8.3. Genetic Engineering
  • 8.4. Vaccine Production
  • 8.5. Virology
  • 8.6. Drug Screening & Toxicity Testing
  • 8.7. Others

9. PRIMARY CELL CULTURE MARKET BY END-USER

  • 9.1. Introduction
  • 9.2. Pharmaceuticals & Bio-Tech Companies
  • 9.3. Research & Academic Institute
  • 9.4. Others

10. PRIMARY CELL CULTURE MARKET BY GEOGRAPHY

  • 10.1. Introduction
  • 10.2. North America
    • 10.2.1. USA
    • 10.2.2. Canada
    • 10.2.3. Mexico
  • 10.3. South America
    • 10.3.1. Brazil
    • 10.3.2. Argentina
    • 10.3.3. Others
  • 10.4. Europe
    • 10.4.1. Germany
    • 10.4.2. France
    • 10.4.3. United Kingdom
    • 10.4.4. Spain
    • 10.4.5. Others
  • 10.5. Middle East and Africa
    • 10.5.1. Saudi Arabia
    • 10.5.2. UAE
    • 10.5.3. Israel
    • 10.5.4. Others
  • 10.6. Asia Pacific
    • 10.6.1. China
    • 10.6.2. India
    • 10.6.3. Japan
    • 10.6.4. South Korea
    • 10.6.5. Indonesia
    • 10.6.6. Thailand
    • 10.6.7. Others

11. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 11.1. Major Players and Strategy Analysis
  • 11.2. Market Share Analysis
  • 11.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 11.4. Competitive Dashboard

12. COMPANY PROFILES

  • 12.1. Thermo Fisher Scientific, Inc.
  • 12.2. Lonza
  • 12.3. Merck KgaA
  • 12.4. Corning Incorporated
  • 12.5. Danaher Corporation
  • 12.6. PromoCell GmbH
  • 12.7. ATCC
  • 12.8. FUJIFILM Corporation
  • 12.9. Mattek (Sartorius)
  • 12.10. Axol Bioscience Ltd
  • 12.11. STEMCELL Technologies Inc.

13. APPENDIX

  • 13.1. Currency
  • 13.2. Assumptions
  • 13.3. Base and Forecast Years Timeline
  • 13.4. Key Benefits for the Stakeholders
  • 13.5. Research Methodology
  • 13.6. Abbreviations